Tag Archives: Cantor Fitzgerald

Array Technologies (ARRY) was Downgraded to a Hold Rating at Cantor Fitzgerald

In a report issued on July 8, Cantor Fitzgerald from Cantor Fitzgerald downgraded Array Technologies (ARRY – Research Report) to Hold, with a price target of $48.00. The company’s shares closed last Tuesday at $39.70. The word on The Street

Array Technologies (ARRY) Initiated with a Buy at Cantor Fitzgerald

In a report issued on January 15, Cantor Fitzgerald from Cantor Fitzgerald initiated coverage with a Buy rating on Array Technologies (ARRY – Research Report) and a price target of $30.00. The company’s shares closed last Tuesday at $39.70. The

Cantor Fitzgerald Reiterates Overweight on Otonomy Shares, Sees 213% Upside For The Stock

In a research report sent to investors on Sunday, Cantor Fitzgerald analyst Charles Duncan reiterated an Overweight rating on Otonomy (NASDAQ:OTIC)with a price target of $11, which represents a potential upside of 213% from where the stock is currently trading.

Aravive (ARAV) Gets an Overweight Rating from Cantor Fitzgerald

In a report issued on August 3, Louise Chen from Cantor Fitzgerald reiterated an Overweight rating on Aravive (NASDAQ: ARAV), with a price target of $30.00. The company’s shares closed last Thursday at $5.65. Currently, the analyst consensus on Aravive

Cantor Fitzgerald initiated Overweight on Amryt Pharma Shares, Sees 291% Upside For The Stock

In a research report issued on Wednesday, Cantor Fitzgerald analyst Brandon Folkes initiated Overweight rating on Amryt Pharma (NASDAQ:AMYT)with a price target of $45, which implies an upside of 291% from current levels. According to TipRanks.com, which measures analysts’ and

Cantor Fitzgerald Reiterates Overweight on Axovant Gene Therapies Shares, Sees 282% Upside For The Stock

In a research report released on 6/23, Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on Axovant Gene Therapies (NASDAQ:AXGT)with a price target of $11, which represents a potential upside of 282% from where the stock is currently trading.